Alberto Mantovani Explained

Alberto Mantovani
Birth Date:29 October 1948
Birth Place:Milan, Italy
Fields:Immunology
Workplaces:University of Milan
Humanitas University
University of Brescia
Mario Negri Institute for Pharmacological Research
Alma Mater:University of Milan
Awards:Robert Koch Prize, see text for others

Alberto Mantovani (born 29 October 1948) is an Italian physician and immunologist. He is Scientific Director of Istituto Clinico Humanitas (Humanitas Clinical and Research Center), President and Founder of the Fondazione Humanitas per la Ricerca, and Professor of Pathology at the State University of Milan.[1] He is known for his works in the roles of the immune system in the development of cancer. His research on tumor-associated macrophages (TAM, an acronym he coined) established inflammation as one of the causes of cancer. He was the first to identify monocyte chemotactic protein - 1 / CCL2 in 1983, and PTX3 in 1997. His works revealed the existence of decoy receptors in cell-signalling. He has been the most cited scientist in Italy, and one of the ten most cited immunologists worldwide.[2]

Biography

Mantovani was born in Milan[1] on 29 October 1948.[3] He studied medicine at the University of Milan and graduated (summa cum laude) in 1973. In 1976 he earned a specialization in oncology at the University of Pavia. Between 1973 and 1976, he worked as a visiting fellow at the Department of Tumor Immunology of the Chester Beatty Research Institute (now the Institute of Cancer Research) in Belmont, Sutton, England, where he continued the studies of Iwan Robert Evans and Peter Alexander. Between 1978 and 1979 he was a visiting fellow at the Laboratory of Immunodiagnosis at the National Institutes of Health in Bethesda, Maryland. In 1979 he was appointed Senior investigator in the Department of Tumor Immunology and Chemotherapy at the Istituto di Ricerche Farmacologiche "Mario Negri" in Milan. He became the Chief of Laboratory of the institute in 1981. In 1987 he worked at the Laboratory of Molecular Immunoregulation of NIH in Frederick, Maryland, as an Eleanor Roosvelt UICC Scholar. In 1994 he was promoted to Full Professor of General Pathology in the School of Medicine at the University of Brescia. He became Head of the Department of Immunology and Cell Biology at Istituto di Ricerche Farmacologiche "Mario Negri" in 1996. Between 2001 and 2014, he also served as Full Professor of General Pathology in the School of Medicine of the State University of Milan. Then he continued as Full Professor of General Pathology at Humanitas University in 2014. In 2005 he became the Scientific Director of Istituto Clinico Humanitas and President of Fondazione Humanitas per la Ricerca (under Humanitas University).[1] [2]

Research activities

Following the deepening of the studies by Robert Evans and Peter Alexander on the role of macrophages in tumour formation,[4] Mantovani discovered that macrophages, rather than helping to shrink the tumor, help it to grow and progress.[5] He gave the acronym for such tumor-associated macrophages as TAM. His work in 2013 showed that targeting TAM is useful for cancer treatment.[6] In 1983, his research team has discovered a protein, known as monocyte chemotactic protein - 1 / CCL2, which is part of the large superfamily of chemokines, which belong to the family of cytokines. His works help to establish the concept of "decoy receptors". From the study of the regulation of the cytokines, Mantovani was able to identify the operating principle of the decoy receptor for interleukin - 1. In 1993, his team showed interleukin-1 type II receptor acts as a decoy in the activity of interleukin 1.[7] His team identified the first member of the long pentraxins, named PTX3 in 1997. The discovery was published in a series of papers.[8] [9] [10] His team demonstrated in 2005 that the chemokine receptor D6 acts as a decoy and scavenger receptor for inflammatory chemokines.[11] In 2015 his research, published in the journal Cell,[12] showed that PTX3 gene is capable of curbing cancer by controlling inflammation.

Works

Scientific Publications

Awards

Honors

Mantovani was appointed "Commander" of the Order of Merit of the Italian Republic in 2005.[17] He was Fellow of the Italian Association Against Leukemias in 1973, and Fellow of the Anna Villa Rusconi Foundation in 1974.[2] He was vice-president/president the International Union of Immunological Societies from 2013 to 2016. He served on the board of the Global Alliance for Vaccines and Immunization (GAVI) between 2007 and 2010. He was president of the International Cytokine Society during 2009–2010.[18]

External links

Notes and References

  1. Biography—Alberto Mantovani, MD. Cancer and Metastasis Reviews. 2010. 29. 2. 239. 10.1007/s10555-010-9219-2. free.
  2. Web site: Mantovani Alberto, MD. www.humanitas-research.org. Humanitas Clinical and Research Center, Italy. 27 July 2016. https://web.archive.org/web/20160625095844/http://www.humanitas-research.org/mantovani-alberto/. 25 June 2016. dead.
  3. Web site: Curriculum vitae: Mantovani Alberto. www.forumecm.it. 29 July 2016.
  4. Evans. R.. Alexander. P.. Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages. Nature. 1972. 236. 5343. 168–170. 10.1038/236168a0. 4553694. 1972Natur.236..168E. 4256131.
  5. Book: Bonavita. E. Galdiero. MR. Jaillon. S. Mantovani. A. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation.. Advances in Cancer Research. 2015. 128. 141–71. 10.1016/bs.acr.2015.04.013. 26216632. 9780128023167.
  6. Web site: The Milstein Award: Alberto Montavani. International Cytokine and Interferon Society (ICIS). 29 July 2016. https://web.archive.org/web/20160807230208/http://www.milstein-award.org/2015/09/alberto-mantovani/. 7 August 2016. dead.
  7. Colotta. F. Re. F. Muzio. M. Bertini. R. Polentarutti. N. Sironi. M. Giri. J.. Dower. S.. Sims. J.. Mantovani. A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 1993. 261. 5120. 472–475. 10.1126/science.8332913. 8332913. 1993Sci...261..472C.
  8. Vouret-Craviari. V. Matteucci. C. Peri. G. Poli. G. Introna. M. Mantovani. A. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan.. Infection and Immunity. 1997. 65. 4. 1345–1350. 9119472. 175138. 10.1128/IAI.65.4.1345-1350.1997.
  9. Basile. A. Sica. A. d'Aniello. E. Breviario. F. Garrido. G. Castellano. M. Mantovani. A. Introna. M. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation.. The Journal of Biological Chemistry. 1997. 272. 13. 8172–8178. 10.1074/jbc.272.13.8172. 9079634. free.
  10. Bottazzi. B. Vouret-Craviari. V. Bastone. A. De Gioia. L. Matteucci. C. Peri. G. Spreafico. F. Pausa. M. D'Ettorre. C. Gianazza. E. Tagliabue. A. Salmona. M. Tedesco. F. Introna. M. Mantovani. A. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.. The Journal of Biological Chemistry. 1997. 272. 52. 32817–32823. 10.1074/jbc.272.52.32817. 9407058. free.
  11. de la Torre. Yeny Martinez. Locati. Massimo. Buracchi. Chiara. Dupor. Jana. Cook. Donald N.. Bonecchi. Raffaella. Nebuloni. Manuela. Rukavina. Daniel. Vago. Luca. Vecchi. Annunciata. Lira. Sergio A.. Mantovani. Alberto. Increased inflammation in mice deficient for the chemokine decoy receptor D6. European Journal of Immunology. 2005. 35. 5. 1342–1346. 10.1002/eji.200526114. 15789340. 39418935. free.
  12. Bonavita. Eduardo. Gentile. Stefania. Rubino. Marcello. Maina. Virginia. Papait. Roberto. Kunderfranco. Paolo. Greco. Carolina. Feruglio. Francesca. Molgora. Martina. Laface. Ilaria. Tartari. Silvia. Doni. Andrea. Pasqualini. Fabio. Barbati. Elisa. Basso. Gianluca. Galdiero. Maria Rosaria. Nebuloni. Manuela. Roncalli. Massimo. Colombo. Piergiuseppe. Laghi. Luigi. Lambris. John D.. Jaillon. Sébastien. Garlanda. Cecilia. Mantovani. Alberto. PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer. Cell. 2015. 160. 4. 700–714. 10.1016/j.cell.2015.01.004. 25679762. free.
  13. Web site: Biotecnologie: Ricerca e Futuro a Biotec Award 1998. 22 June 1998.
  14. Biography—Alberto Mantovani, MD. Cancer and Metastasis Reviews. 29. 2. 239. 10.1007/s10555-010-9219-2. 2010. free.
  15. Web site: Featuring the Guest Editor Alberto Mantovani. 4 December 2020.
  16. Web site: THE PEZCOLLER FOUNDATION-AACR INTERNATIONAL AWARD . Pezcoller Foundation . 6 November 2019.
  17. Web site: Commendatore Ordine al Merito della Repubblica Italiana . presidenti.quirinale.it . Presidenza della Republica . 28 July 2016 . it . dead . https://web.archive.org/web/20160818074514/http://presidenti.quirinale.it/elementi/Onorificenze.aspx?pag=65&qIdOnorificenza=60&cognome=&nome=&daAnno=1800&aAnno=2015&luogoNascita=&testo=&ordinamento=2 . 18 August 2016 .
  18. Web site: Prof Alberto Mantovani. Efranat, Inc.. 28 July 2016. https://web.archive.org/web/20160819123728/http://efranat.com/About-Us/643.aspx. 19 August 2016. dead. dmy-all.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alberto Mantovani".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.